First patient dosed in Qlaris Bio's phase 2 Nightingale clinical trial for QLS-111

Published on August 26, 2025
The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients with normal tension glaucoma.
Continue reading on website
Other news

The important role daily disposables play in your practice

August 26, 2025
Sheila Setork, OD, gives insight and advice on how to optimize daily disposables in order to improve retention rates and introduce more patients to contact lenses.

Myopia May Protect Against Diabetic Retinopathy

August 27, 2025
This study is the first to demonstrate a casual relationship between myopia and DR by analyzing single nucleotide polymorphisms associated with different forms of ametropia. Its findings may have implications for future research on DR risk among patients with refractive error. Photo: Steven Ferrucci, OD. Click image to enlarge. Several observational studies have indicated th